Thermo Fisher Scientific TMO Asia-Pacific — Consolidated revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Thermo Fisher Scientific's asia-pacific — consolidated revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Thermo Fisher Scientific's asia-pacific — consolidated revenues?
- Thermo Fisher Scientific (TMO) reported asia-pacific — consolidated revenues of $1.97B in Q1 2026.
- How has Thermo Fisher Scientific's asia-pacific — consolidated revenues changed year-over-year?
- Thermo Fisher Scientific's asia-pacific — consolidated revenues increased by 4.2% year-over-year, from $1.89B to $1.97B.
- What is the long-term trend for Thermo Fisher Scientific's asia-pacific — consolidated revenues?
- Over 4 years (2021 to 2025), Thermo Fisher Scientific's asia-pacific — consolidated revenues has grown at a 2.9% compound annual growth rate (CAGR), from $7.22B to $8.1B.
- What does asia-pacific — consolidated revenues mean?
- The total revenue earned by the company from all business activities conducted within the Asia-Pacific region.
- How do you interpret asia-pacific — consolidated revenues?
- An increase indicates successful market expansion, strong regional demand, or effective sales execution in the Asia-Pacific territory, while a decrease may signal regional economic headwinds, increased local competition, or supply chain disruptions.
- How does asia-pacific — consolidated revenues compare across companies?
- Peers in the life sciences and diagnostics sector typically report regional revenue to demonstrate geographic diversification and exposure to high-growth markets like China and India.